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Abstract
Somatic cells reprogrammed into induced pluripotent stem cells (iPSCs) acquire features of human embryonic stem cells
(hESCs) and thus represent a promising source for cellular therapy of debilitating diseases, such as age-related disorders.
However, reprogrammed cell lines have been found to harbor various genomic alterations. In addition, we recently
discovered that the mitochondrial DNA of human fibroblasts also undergoes random mutational events upon
reprogramming. Aged somatic cells might possess high susceptibility to nuclear and mitochondrial genome instability.
Hence, concerns over the oncogenic potential of reprogrammed cells due to the lack of genomic integrity may hinder the
applicability of iPSC-based therapies for age-associated conditions. Here, we investigated whether aged reprogrammed
cells harboring chromosomal abnormalities show resistance to apoptotic cell death or mitochondrial-associated oxidative
stress, both hallmarks of cancer transformation. Four iPSC lines were generated from dermal fibroblasts derived from an 84-
year-old woman, representing the oldest human donor so far reprogrammed to pluripotency. Despite the presence of
karyotype aberrations, all aged-iPSCs were able to differentiate into neurons, re-establish telomerase activity, and
reconfigure mitochondrial ultra-structure and functionality to a hESC-like state. Importantly, aged-iPSCs exhibited high
sensitivity to drug-induced apoptosis and low levels of oxidative stress and DNA damage, in a similar fashion as iPSCs
derived from young donors and hESCs. Thus, the occurrence of chromosomal abnormalities within aged reprogrammed
cells might not be sufficient to over-ride the cellular surveillance machinery and induce malignant transformation through
the alteration of mitochondrial-associated cell death. Taken together, we unveiled that cellular reprogramming is capable of
reversing aging-related features in somatic cells from a very old subject, despite the presence of genomic alterations.
Nevertheless, we believe it will be essential to develop reprogramming protocols capable of safeguarding the integrity of
the genome of aged somatic cells, before employing iPSC-based therapy for age-associated disorders.
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Introduction
A novel strategy to derive pluripotent stem cells from adult
somatic tissue, called cellular reprogramming, recently revolution-
ized the field of regenerative medicine [1,2]. In comparison to
human embryonic stem cells (hESCs), induced pluripotent stem
cells (iPSCs) exhibit two major advantages: (i) their generation is
not hampered by the ethical issues commonly associated with
blastocyst-derived stem cells and (ii) they represent individual-
specific isogenic cells. Thus, iPSCs hold the potentiality to be used
for personalized drug-screening [3], and patient-tailored regener-
ative therapies without the risk of immune rejections [4]. The
iPSC technology is of particular interest in the context of age-
associated disorders, such as Alzheimer’s and Parkinson’s disease,
which affect a growing number of people and currently lack
efficacious treatments.
Unfortunately, loss of genome integrity has been observed
within hESCs and iPSCs by different groups [5,6]. In particular,
the reprogramming process has been found linked to a high
mutation rate [7,8,9]. Additionally, we recently unveiled that the
mitochondrial genome of human fibroblasts also undergoes
random mutational events upon the induction of pluripotency
[10]. Aged somatic cells might be even more susceptible to nuclear
and mitochondrial genome instability, due to an aging-related
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increase in oxidative DNA damage [11]. Genes involved in
genome integrity have been shown to be repressed with advancing
age [12] and maternal aging positively correlates with the rate of
aneuploidy [13]. Accordingly, chromosomal aberrations have
been recently observed in iPSC lines obtained from elderly
individuals [14].
The reprogramming-associated genomic alterations may exert a
tumorigenic effect. Indeed, deletions of tumor-suppressor genes
have been detected during reprogramming, while duplications of
oncogenic genes have been observed upon extended culture [5,6].
Moreover, point mutations within cancer-related genes were
identified within iPSC lines derived with various reprogramming
methods [7,8,9]. Nonetheless, no particular tumorigenic mecha-
nism has yet been identified as consistently functionally implicated
during iPSCs generation or upon their adaptation in culture. In
accordance, genomic aberrations within iPSCs did not alter their
cellular functionality [7,8,9,14] and mitochondrial DNA (mtDNA)
modifications did not affect the reprogramming-associated re-
modulation of energy metabolism [10]. Hence, it is essential to
understand the biological significance of reprogramming-induced
genetic alterations and to determine whether their presence can
truly enhance the oncogenic potential of individual iPSC lines.
Besides aneuploidy, an important hallmark of cancer cells is
their resistance to apoptosis [15]. This ability to escape cell death is
in fact essential to achieve unlimited and uncontrolled prolifera-
tion. Recent data has demonstrated that activation of apoptosis
has a mediatory role in the induction of pluripotency, as two main
proteases involved in programmed cell death, Caspases 3 and 8,
are activated by OCT4 [16]. Mouse and human ESCs possess
profound susceptibility to apoptosis-inducing DNA damaging
agents [17,18]. Human iPSCs have also been found to exhibit
hypersensitivity to DNA damaging agents following c-irradiation,
which results in rapid induction of apoptosis [19]. Thus, it is
important to examine whether genomic abnormalities within
pluripotent stem cells might induce oncogenic transformation by
altering the susceptibility to apoptosis, a mechanism essential for
safe-guarding against uncontrolled cancer-like proliferation.
Cell death mechanisms are tightly regulated by mitochondria,
which, besides being the cellular powerhouse, are the active site of
apoptotic induction and reactive oxygen species (ROS) generation
[20]. Over time, the presence of mitochondrial dysfunctions may
exert cellular detrimental effects leading to imbalances in energy
production, modulation of programmed cell death, or redox
maintenance. In fact, oxidative stress induces the accumulation of
mutational damage within mtDNA [21], which in turn can cause
multiple cellular dysfunctions [22,23]. We and others have
recently demonstrated that somatic mitochondria undergo a
complex remodeling upon reprogramming, as they adapt their
morphology and functionality to attain the pluripotent state
[24,25,26]. Therefore, iPSC generation modulates mitochondrial-
related pathways to dictate the acquirement of a hESC-like redox
homeostasis.
In the present work, we investigated whether the presence of
chromosomal aberrations may be linked to tumorigenicity by an
alteration of mitochondrial-associated cell death mechanisms. This
was conducted in skin-derived cells from very old individuals,
which might harbor alterations in signaling pathways related to
mitochondria and oxidative stress [27], and thus may be more
prone to genomic instability. Four iPSC lines were generated from
dermal fibroblasts obtained from an 84-year-old woman, which to
our knowledge represent the most aged human donor cells
reprogrammed to pluripotency. All lines exhibited chromosomal
abnormalities that were not observed in any of the iPSC lines we
have derived in our laboratory from young individuals
[10,26,28,29]. These aberrations included the enrichment of
pluripotency and cancer-associated genes. Nevertheless, the
presence of karyotype variations did not affect the ability of
aged-iPSC lines to re-establish telomerase activity, differentiate
into neuronal cells in vitro, or induce X-chromosome reactivation.
Importantly, mitochondria ultra-structural morphology and func-
tionality as well as mitochondrial modulation of programmed cell
death and ROS generation were also reset to an embryonic-like
state regardless of chromosomal abnormalities. Both young and
aged donor-derived iPSCs exhibited a similar hESC-like hyper-
sensitivity to apoptosis and low levels of ROS and DNA damage.
Overall, our data suggest that the presence of chromosomal
aberrations within aged reprogrammed cells may not exert a
detrimental effect by inducing a reduction of cell death or an
increased in cellular oxidative stress, which are necessary
mechanisms for tumor development and progression.
Results
Generation and characterization of aged donor-derived
iPSCs
Aged donor-derived dermal fibroblasts were obtained from an
84-year-old woman (NFH2) affected by age-associated medical
conditions, including late-onset diabetes type II, hypertension, and
renal failure (Table S1). NFH2-iPSCs were generated by retroviral
transduction of the Yamanaka cocktail (OCT4, KLF4, SOX2, and
c-MYC) [1]. Four iPSC lines were established and fully
characterized: OiPS3, OiPS6, OiPS8, and OiPS16 (Figure 1A).
All lines exhibited hESC-like morphology and growth rate,
alkaline phosphatase (AP) activity, expression of pluripotency-
associated markers NANOG, SSEA4, TRA-1-60, TRA-1-81, and
the genetic fingerprinting pattern of NFH2 parental fibroblasts
(Figure S1). The four aged-iPSC lines were compared to two
hESCs (H1 and H9) and to four iPSC lines previously generated
from two neonatal foreskin fibroblasts: iPS2 and iPS4 from HFF1
fibroblasts and iB4 and iB5 from BJ fibroblasts [26]. All aged-iPSC
lines acquired a gene expression signature similar to that of hESCs
(Pearson correlation value: 0.89) and young donor-derived iPSCs
(Pearson correlation value: 0.82) and distinct from that of the
parental NFH2 fibroblasts (Pearson correlation value: 0.67)
(Figure 1B, Figure S2).
The differentiation potential of aged donor-derived iPSCs was
tested both in vitro and in vivo. All lines could successfully
differentiate in vitro into all three embryonic germ layers, as
detected by the expression of marker proteins specific for
ectoderm, NESTIN and TUJ-1, for mesoderm, SMOOTH
MUSCLE ACTIN (SMA) and BRACHYURY (T), and for
endoderm, SOX17 and ALPHA FETO PROTEIN (AFP)
(Figure 1C). Two aged-iPSC lines (OiPS6 and OiPS16) were
able to generate teratomas containing derivatives of all three
germ layers. However, the presence of known endoderm-
associated structures could not be identified within teratoma
samples of the remaining two iPSC lines (OiPS3 and OiPS8)
(Figure S3). Additional studies are ongoing to determine whether
these two lines conclusively exhibit a real impairment toward
endoderm differentiation in vivo or the observation is potentially
due to the deficiencies inherent to the current teratoma assays
[30].
Chromosomal aberrations in aged reprogrammed cells
Genetic integrity of the four aged donor-derived iPSC lines was
first assessed by karyotyping. The analysis revealed the presence of
chromosomal abnormalities that were not detected in the parental
NFH2 fibroblast cells (Figure 2). These results were unexpected,
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since all young donor-derived iPSC lines (from neonate foreskin
fibroblasts, from amniotic fluid cells, and from chorionic villi cells)
previously established in our laboratory bore no karyotype
abnormalities [10,26,29,31]. The aberrations detected in aged-
iPSCs included trisomy of chromosome 20 (in OiPS3 and OiPS6),
translocation between chromosome 2 and 10 (in OiPS3, OiPS6,
Figure 1. Derivation and characterization of four iPSC lines from an 84-year-old woman. (A) NFH2 dermal fibroblasts were obtained from
an 84-year-old woman and transduced using retroviruses containing the four transcription factors (TFs) OCT4, KLF4, SOX2 and c-MYC. Four weeks
later, hESC-like colonies were stained for alkaline phosphatase (AP) activity then manually picked for further characterization. Four distinct iPSC lines
were established: OiPS3, OiPS6, OiPS8, and OiPS16. (B) Hierarchical clustering of all fibroblast cells and pluripotent stem cells. NFH2-derived iPSC lines
acquired a pluripotent stem cell-like transcriptional signature and clustered far apart from the parental NFH2 fibroblasts and from other fibroblast
cells. (C) Embryoid body (EB)-based in vitro differentiation of the four NFH2-derived iPSC lines. All differentiated NFH2-iPSC lines expressed marker
proteins specific to the three germ layers: ectoderm (NESTIN and TUJ-1), mesoderm (SMOOTH MUSCLE ACTIN (SMA) and BRACHYURY (T)), and
endoderm (SOX17 and ALPHA FETO PROTEIN (AFP)). Scale bars, 20 mm.
doi:10.1371/journal.pone.0027352.g001
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and OiPS8), trisomy of chromosome 1 (in OiPS16) and loss of
chromosome 21 (in OiPS16). OiPS16 exhibited a mixed
population, where a portion of cells harbored a normal karyotype,
while the remaining acquired chromosomal abnormalities
(Figure 2, red circles and light blue circles).
To investigate genome instability in more detail, we analyzed
chromosomal integrity using a recently published gene expres-
sion-based approach [6]. Transcriptome data of young and old
donor-derived iPSCs were compared to their corresponding
parental fibroblast cells. For hESCs, the expression values were
presented with reference to the median of all pluripotent stem
cells included in the dataset [6]. Significant chromosomal
enrichment (Bonferroni corrected p-values ,1024) could be
confirmed in all trisomy cases, namely chromosome 20 in OiPS3
and OiPS6, and chromosome 1 in OiPS16 (Figure 2, red circles).
In addition, significant enrichment could be identified in
chromosomes that were found complete upon karyotyping,
including chromosome 12 in H1 and OiPS8, chromosome 16
in iPS4 and iB5, chromosomes 17 in OiPS8, chromosome 9 in
OiPS3, and chromosome X in OiPS6 (Figure 2 and Figure S4).
Nevertheless, gene expression-based analysis failed to confirm the
10 to 2 translocation (found in lines OiPS3, OiPS6, and OiPS8)
and the 21 loss detected in a sub-population of OiPS16 (Figure 2,
light blue circles). Hence, this approach might not be appropriate
to detect genomic changes occurring in short chromosomes
within a mixed population, as already pointed out [5], or to
identify chromosomal translocations. Indeed, although a portion
of chromosome 10 was physically located on chromosome 2, the
genes of the misplaced chromosomal area were still assigned to
chromosome 10, and thus considered unaffected by gene
expression-based analysis.
Recent data suggest that certain types of aneuploidies within
hESCs and iPSCs may induce a proliferative advantage by
increasing the expression pluripotency-associated genes [5,6].
Interestingly, chromosome 1 and 20, which exhibited a trisomic
transformation within our aged-iPSC lines, were among the most
frequently affected chromosomes harboring chromosomal gain
[6] and copy number variation [5] in hESCs and iPSCs. Moving
average plot analysis revealed that genes such as LIN28, LEFTY1
and LEFTY2 on chromosome 1 (Figure 3A) and DNMT3B and
SALL4 on chromosome 20 (Figure 3B), known to be involved in
the regulation of pluripotency, were indeed significantly enriched
in NFH2-iPSCs compared to the parental NFH2 fibroblasts. Up-
regulated genes comprised members of transcription factor
families associated with reprogramming, such as the POU family
(POU2F1 and POU3F1) and the Kruppel-like family (KLF14)
(Figure 3). Moreover, genes regulating proliferation and linked to
tumorigenicity, such as JARID1B, PCNA, TGIF2, and the p53
target gene GADD45A, were also detected among the genes
within chromosome 1 and 20 enriched in NFH2-iPSCs compared
to NFH2 fibroblasts (Figure 3). The complete list of significantly
altered genes in all our pluripotent stem cell lines is reported in
Table S2.
Chromosomal aberrations within aged-iPSCs do not
affect neuronal differentiation, X-chromosome
inactivation (XCI), and telomerase activity
In order to test whether chromosomal aberrations could
hamper differentiation capabilities, the four aged donor-derived
iPSC lines were subjected to direct neuronal differentiation.
Neuronal cells were generated following a recently published
adherent protocol, which requires the exposure to TGF-b receptor
inhibitor (SB) and MEK1/2 inhibitor (PD) [32]. All lines (OiPS3,
OiPS6, OiPS8, and OiPS16) successfully differentiated into
neurons expressing the neuronal-associated proteins PAX6,
NESTIN, and TUJ-1, in a similar fashion to the hESC lines H1
and H9 (Figure 4A). These results are in agreement with a recent
study showing that karyotype variations within iPSCs obtained
from elderly subjects did not affect their capacity to differentiate
into functional motor neurons [14].
The state of X-chromosome inactivation (XCI) was assessed in
the four iPSC lines and compared to that of the female hESC line
H9. In agreement with previous findings [33], we detected a
varied XCI status in all female pluripotent stem cells, with a subset
of cells clearly expressing an inactive X-chromosome (Xi)
(Figure 4B, white arrows). The XCI pattern in iPSCs obtained
from the 84-year-old woman was similar to that exhibited by the
embryonic stem cell line H9, thus suggesting that donor age and
chromosomal abnormalities do not influence the impaired ability
of human pluripotent stem cells to complete Xi-reactivation under
normoxic conditions [16].
Telomerase, the enzyme responsible for telomere elongation, is
active in stem cells and germ cells but normally inactive in somatic
cells [34]. Cellular reprogramming has been found able to restore
telomerase activity in young human healthy somatic cells [1], in
mouse fibroblasts from old donors [35], and in human fibroblasts
obtained from patients affected by dyskeratosis congenita (DC), a
disease affecting telomere maintenance causing premature aging
[36]. Thus, we asked whether re-activation of telomerase could
also occur in human somatic cells derived from an elderly subject.
Indeed, telomerase activity was remarkably elevated in all aged-
iPSC lines compared to the parental NFH2 fibroblasts and to
other fibroblast cells derived from young and aged individuals
(Figure 4C). Importantly, the level of telomere activation in the old
donor-derived iPSCs was comparable to that of hESCs and young
donor-derived iPSCs, implying that aging and karyotype alter-
ations do not impair the reprogramming-induced restoration of
telomerase activity.
Aged-iPSCs with karyotype abnormalities acquire hESC-
like mitochondrial morphology and functionality
Ultra-structural studies showed that mitochondria exhibit a
typical configuration within hESCs, with round-shaped morphol-
ogy and poorly developed cristae [37]. Similar features have been
recently observed in mouse iPSCs [38] and human iPSCs [25,26].
We thus aimed to investigate whether the same could hold true for
Figure 2. Chromosomal aberrations in aged reprogrammed cells. Left panel, karyotype analysis of the parental NFH2 fibroblast cells and
NFH2-derived iPSC lines. NFH2 was karyotypically normal, while all NFH2-iPSC lines exhibited chromosomal aberrations (red circles and light blue
circles). Right panel, transcriptional profiling-based analysis of chromosomal integrity. Expression values of single genes in NFH2-iPSC lines were
compared to the parental NFH2 fibroblasts and considered over-expressed when fold-change.2 and Bonferroni corrected p-values ,1024. The
analysis confirmed significant enrichment in all cases in which karyotyping showed trisomic transformation (red circles). Additional significant
enrichments could be observed in NFH2-iPSCs in chromosomes that appeared normal upon karyotyping. Chromosomal translocations (10 to 2) in
OiPS3, OiPS6, OiPS8 and chromosomal 1 loss in OiPS16 could not be confirmed by gene expression-based chromosomal enrichment analysis (light
blue circles).
doi:10.1371/journal.pone.0027352.g002
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iPSC lines obtained from somatic fibroblasts from very old
individuals.
Transmission electron microscopy (TEM) images revealed that
mitochondria in all fibroblast cells possess an overall comparable
morphology, characterized by tubular shape and densely-packed
cristae (Figure 5A). This was observed in both neonatal fibroblasts
(HFF1) and in three aged-derived fibroblasts: NFH2 from an 84-
year-old woman, NFH17 from an 80-year-old man, and NFH18
from an 80-year-old woman (see Table S1 for clinical details). On
the other hand, the female hESC line H9 and the HFF1-derived
iPSC line iPS4 showed a round-shaped morphology with sparse
cristae, in agreement with previous results [25,26]. Remarkably,
the same ultra-structural traits could be identified in NFH2-
derived iPSC lines OiPS3 and OiPS6. Quantitative measurement
of mitochondrial diameters confirmed that both H9 and NFH2-
iPSCs exhibit a decreased long diameter and increased short
diameter, indicative that the organelles’ structural morphology
changes from tubular to round-shaped (Figure 5B and 5C). Thus,
cellular reprogramming can overcome the age limitations to reset
the mitochondrial morphology of somatic cells to an embryonic-
like state, an ability that is not tainted by the presence of genomic
alterations.
To assess mitochondrial functionality of aged reprogrammed
cells, we analyzed the relative mitochondrial membrane potential
(MMP), which is an important parameter of mitochondrial
function, membrane integrity, and energy coupling. It has been
recently demonstrated that MMP is elevated in undifferentiated
human ESCs [39] and iPSCs [24], it decreases upon differenti-
ation [24], and it becomes higher in MEFs undergoing the
reprogramming process [40]. This pluripotency-associated mito-
chondrial hyper-polarization is believed to be a sign of reduced
ATP consumption, which is indicative of glycolysis-based energy
metabolism. Indeed, a switch from oxidative to glycolytic
metabolism has been demonstrated in both human iPSCs
[10,26,41] and murine iPSCs [40]. In agreement with these
findings, we observed that MMP was low in all fibroblast cells, but
increased in aged-iPSC lines OiPS3, OiPS6, and OiPS8, in a
similar fashion to young iPSC lines iB4 and iPS4 and to hESC line
H9 (Figure 5D). Moreover, spontaneously differentiated cells at
the borders of all pluripotent stem cell colonies displayed lower
mitochondrial membrane fluorescence (Figure 5D). Importantly,
the re-establishment of hESC-like mitochondrial functionality was
also confirmed in two additional aged-iPSC lines (Figure S5),
which were generated from dermal fibroblasts derived from an
unrelated 82-year-old woman (Hossini et al, unpublished).
Overall, mitochondrial energy-coupling and functionality ap-
peared restored in aged iPSCs to a status similar to that of young
iPSCs and hESCs, which is in accordance with the findings related
to the ultra-structural mitochondrial morphology. Hence, the
occurrence of genomic aberrations within aged reprogrammed
Figure 3. Enrichment of pluripotency and tumorigenicity-associated genes within chromosomes 1 and 20 in aged-iPSCs. (A) Moving
average plot analysis of chromosome 1. Expression values in NFH2-iPSC lines were compared to the parental NFH2 fibroblasts and considered over-
expressed or under-expressed when fold-change.2. Each dot represents a probeset encompassing an individual gene. Highlighted in different colors
are probeset for genes whose function has been associated with pluripotency, reprogramming, proliferation, or tumorigenicity. (B) Moving average
plot analysis of chromosome 20. Moving average plots were produced using R/Bioconductor package GenomeGraphs.
doi:10.1371/journal.pone.0027352.g003
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Figure 4. Neuronal differentiation, X-chromosome inactivation, and telomerase activity in aged donor-derived iPSCs. (A) Neuronal
cells were derived by the combined treatment of transforming growth factor b(TGFb) receptor inhibitor and MEK1/2 inhibitor. All aged-iPSC lines
generated neuronal-like cells expressing PAX6, NESTIN, and TUJ-1, in a similar fashion to the hESC lines H1 and H9. Scale bars, 10 mm. (B) X-
chromosome inactivation (XCI) was assayed by H3K27me3 immunostaining. OCT4 staining was used to distinguish undifferentiated pluripotent stem
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cells did not negatively affect the reprogramming-induced
mitochondrial and metabolic modulation.
Chromosomal abnormalities within aged-iPSCs do not
influence the re-establishment of apoptosis signaling
Apoptosis play a pivotal role in oncogenic transformation.
Hence, we sought to investigate whether the presence of
chromosomal aberrations could have a tumorigenic effect by
altering apoptotic responses. Apoptosis was detected both at the
basal level and upon treatment with two different concentrations
(1029 M and 1027 M) of the cytostatic agent actinomycin D (AM),
which causes cell cycle arrest and induces apoptotic cell death, in
young and aged-derived fibroblasts, hESCs, and young and aged-
derived iPSCs.
All fibroblast cells exhibited similar induction of apoptosis.
Although NFH2 fibroblasts showed the presence of cell death after
24 h treatment with the highest concentration of AM (Figure 6A
and 6B), all the other young and aged-derived fibroblasts started
inhibiting cell proliferation activity only upon 48 h exposure to
high doses of AM (Figure 6A and 6C). Conversely, pluripotent
stem cells showed higher basal apoptosis activity and increased
sensitivity to drug-induced apoptotic cell death. After a 24 h
cells from MEFs. NFH2 fibroblasts clearly exhibited inactive X-chromosomes (Xi), while variable XCI status was observed in both H9 and NFH2-derived
iPSC lines. Single female pluripotent cells expressing Xi are indicated by the white arrows in the bottom inserts. Scale bars, 10 mm. (C) Telomerase
activity was low in fibroblasts from neonates (HFF1 and BJ) and from adult individuals of various ages (NFH13-55y, NFH2-84y, NFH17-80y, and NFH18-
80y). The level of activity was similarly elevated in all pluripotent stem cells, including hESCs (H1 and H9), HFF1-iPSCs (iPS2 and iPS4), BJ-iPSCs (iB4 and
iB5) and NFH2-iPSCs (OiPS3, OiPS6, OiPS8, and OiPS16). Heat inactivation was performed to show the different enzymatic activity between the active
and inactive state. TPC, telomerase positive extract control (100 ng of positive control cell protein extract provided by the kit); MTC, minus telomerase
control (cell sample substituted by CHAPS Lysis Buffer); NTC, no template Control (cell sample substituted by water). Error bars indicate standard
deviation.
doi:10.1371/journal.pone.0027352.g004
Figure 5. iPSCs from an 84-year-old woman acquired embryonic-like mitochondrial ultra-structure and functionality. (A)
Transmission electron microscopy (TEM) analysis showing mitochondrial ultra-structural morphology in fibroblasts and in pluripotent stem cells.
HFF1, neonatal fibroblasts; NFH2, dermal fibroblasts from an 84-year-old woman; NFH17 from an 80-year-old man; NFH18 from an 80-year-old
woman; H9, female hESC line; iPS4, iPSC line derived from HFF1 fibroblasts; OiPS3 and OiPS6, iPSC lines generated from NFH2 fibroblasts. Scale bars,
500 nm. (B–C) Measurement of long and short mitochondrial diameters in NFH2 fibroblasts and in two NFH2-derived iPSC lines (OiPS3 and OiPS6). 50
mitochondria were measured for each sample using the EMMENU4 software (Fastscan, TVIPS). Upon reprogramming the long diameter becomes
shorter while the short diameter increases, suggesting that the organelles tend to acquire a round-like shape. Error bars indicate the standard error of
means (SEM). (D) Mitochondrial membrane potential (MMP) was assessed employing the fluorescent dye TMRE in live cells to obtain a relative
measurement of mitochondria functionality in terms of energy coupling. All human fibroblasts exhibited low basal MMP. The fluorescent intensity
appeared increased in undifferentiated hESCs and iPSCs, while differentiated cells at the borders of pluripotent stem cell colonies showed reduction
of basal MMP signal. Thus, the mitochondrial functionality of aged iPSCs appeared similar of that of young iPSCs and hESCs. The presence of
mitochondrial hyper-polarization, suggestive of reduced ATP consumption, in all pluripotent stem cells is in agreement with the distinctive metabolic
features of undifferentiated stem cells which rely more on glycolytic rather than oxidative-based energy generation. Scale bars, 50 mm.
doi:10.1371/journal.pone.0027352.g005
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treatment with low doses of AM (1029 M), hESCs, young-iPSCs,
and aged-iPSCs exhibited a striking induction of apoptosis
(Figure 6A and 6D), which further increased after 48 h
(Figure 6A and 6E). Importantly, although one aged-iPSC line
(OiPS6) showed slightly higher apoptotic levels than the other
pluripotent stem cells, the remaining aged donor-derived iPSCs
exhibited an overall susceptibility to actinomycin D-induced
apoptosis similar to that of hESCs and young donor-derived
iPSCs.
Transcriptional analysis of the status of the apoptotic pathway
indicated the consensual up-regulation of several apoptosis-related
genes in all pluripotent stem cells compared to somatic fibroblasts,
these include BIK, CASP3, HRK, TNF, TNFRSF10A-21-25, and
TRAF2-4 (Figure S6). Taken together, all pluripotent stem cells
analyzed possessed a similar hypersensitivity to cytostatic agent-
induced apoptosis. Hence, karyotype variations within aged
donor-derived iPSC lines might not predispose to cancer by
altering the reprogramming-induced modulation of programmed
cell death.
Reprogramming endows aged cells with the ability to
maintain low levels of ROS and DNA damage despite the
presence of genomic aberrations
We previously demonstrated that cellular reprogramming
restores a cellular state characterized by low oxidative stress levels
[26]. Independent findings corroborate these results and showed
Figure 6. Sensitivity to drug-induced apoptosis in young and aged fibroblasts, hESCs, young-iPSCs, and aged-iPSCs. (A) Apoptotic
cell death was measured both at the basal level and upon the treatment with two different doses of actinomycin D (AM) (1029 M and 1027 M).
Pictures were taken after 24 h and 48 h. Scale bars, 100 mm. (B) Induction of apoptosis after 24 h AM treatment in young and aged-derived
fibroblasts. (C) Apoptosis levels after 48 h AM treatment in young and aged-derived fibroblasts. (D) Apoptotic cell death at 24 h in hESCs, young-
iPSCs (iPS2, iPS4, iB4, iB5) and aged-iPSCs (OiPS3, OiPS6, OiPS8, OiPS16). (E) Induction of apoptosis after 48 h AM treatment in pluripotent stem cells.
doi:10.1371/journal.pone.0027352.g006
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that human iPSC have similar antioxidant defenses to hESCs [24].
Here, we asked whether this resetting of the cellular redox state
could also occur within iPSCs with chromosomal abnormalities
which were derived from very old donors, which may bear higher
levels of oxidative stress and ROS-mediated DNA damage [11].
Young and aged-derived fibroblasts showed an overall compa-
rable production of ROS at basal levels and after 24 h of
treatment with high doses of actinomycin D (AM) (1026 M)
(Figure 7A). The same AM concentration gave rise to almost
complete cell death in pluripotent stem cells, due to the detected
hypersensitivity to AM-induced apoptosis. However, basal levels of
ROS in hESCs, young-iPSCs, and aged-iPSCs were highly
reduced compared to somatic fibroblasts (Figure 7B). Importantly,
the amount of ROS generated by aged donor-derived iPSCs was
similar to that of young donor-derived iPSCs and hESCs.
ROS are known to oxidize DNA and indeed 8-hydroxy-29-
deoxyguanosine (8OHdG), a repair product of oxidized guanine
lesions, can accumulate in both nuclear and mitochondrial DNA
(mtDNA) and has been identified as a biomarker for oxidative
stress [42]. The presence of cytoplasmic 8OHdG basal immuno-
reactivity, indicative of mtDNA lesions, was observed within
fibroblasts obtained from elderly subjects (NFH2-84y, NFH17-
80y, and NFH18-80y) (Figure 7C). Exposure to 500 mM of H2O2
for two hours led to increased 8OHdG signals in all fibroblasts
analyzed (Figure 7C). Conversely, hESCs, young-iPSCs, and aged-
iPSCs did not show signs of oxidative lesions to DNA (nuclear or
mitochondrial), even after treatment with the pro-oxidant agent
H2O2 (Figure 7D).
Transcriptional profiling data showed that anti-oxidant related
genes such as CAT, GPX1, SOD3 and AOX1, known to be involved
in the response to oxidative stress, were consensually down-
regulated in all pluripotent stem cells in comparison to fibroblasts,
possibly due to the diminished need for counter-acting oxidative
stress (Figure S7). Overall, the findings are in agreement with
previously published data obtained in young donor-derived iPSCs
[24,26] and suggest that aged reprogrammed cells may be able to
erase aging-associated mtDNA damage and re-establish redox
homeostasis similar to that in hESCs, regardless of the presence of
chromosomal aberrations.
Discussion
Genome integrity is of critical importance for iPSC-based
clinical applications. Recent findings showing the presence of
nuclear and mitochondrial genomic alterations within human
reprogrammed cells are causing growing concerns that tumorige-
Figure 7. ROS and DNA damage in aged donor-derived iPSCs. (A) Production of ROS in fibroblast cells was measured by FACS using DCF-DA
at basal level and after 24 h treatment with high doses actinomycin D (AM) (1026 M). Analysis was conducted in quadruplicate and reported as
fluorescence intensity. Error bars indicate standard deviation. (B) Representative DCF-DA-based FACS measurements of basal ROS generation in two
fibroblasts (HFF1 and BJ), two hESC lines (H1 and H9), two young donor-derived iPSC lines (iB4 and iB5), and two aged donor-derived iPSC lines
(OiPS3 and OiPS6). (C) Oxidative damage to nuclear and mitochondrial DNA within fibroblast cells was assessed by 8-hydroxy-29-deoxyguanosine
(8OHdG) staining. Treatment with 500 mM H2O2 for two hours was employed to trigger oxidative-mediated DNA damage. Scale bars, 10 mm. (D)
Embryonic and somatic-derived pluripotent stem cells were stained with an antibody against 8OHdG to detect nuclear or mitochondrial DNA lesions
induced by oxidative stress. The analysis was conducted in standard growth conditions and after a 2 h exposure to 500 mM H2O2. Scale bars, 10 mm.
doi:10.1371/journal.pone.0027352.g007
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nicity might ultimately hinder the clinical applicability of iPSCs
[5,6,7,8,9,10]. In order to distinguish harmless variations from
those impairing the functionality or promoting clinical risks, it is
then essential to investigate the biological consequences of these
modifications within distinct human iPSC lines.
The detected chromosomal abnormalities have so far not been
strongly linked with a functional defect. Pasi et al. observed that
genomic aberrations might be transient and that they do not
compromise cellular functionality [7], while Boulting et al. showed
that several iPSC lines harboring karyotype variations could pass a
stringent test of differentiation capacity [14]. Moreover, the
presence of mitochondrial mutations within human iPSCs did not
affect the reprogramming-induced modulation of bioenergetic
metabolism [10]. Our current results are in agreement with these
findings and further suggest that chromosomal abnormalities do
not impart a negative effect on pluripotency and reprogramming-
related functions, such as telomerase activity, X-chromosome
activation, neuronal differentiation, and mitochondrial and
metabolic re-configuration.
Oncogenic transformation is linked with a loss of apoptotic
susceptibility. On the other hand, both young and aged donor-
derived iPSCs and hESCs showed hypersensitivity to drug-
induced apoptosis, regardless of chromosomal aberrations. This
is in accordance with the high susceptibility to apoptotic cell death
that pluripotent stem cells have been found to exhibit upon
exposure to c-irradiation [19]. Redox imbalance and DNA
damage are additional traits of tumour development. However,
the hESC and iPSC lines we tested showed low concentration of
ROS and lack of oxidative damage to mitochondrial or nuclear
DNA. Taken together, the data suggest that if genomic aberrations
might confer oncogenic properties to pluripotent stem cells, this
may not be due to the alteration of mitochondrial-associated cell
death mechanisms.
Future studies will have to address whether additional cell death
pathways, such as autophagy, might also be conserved in iPSCs
bearing genomic variations. It is also worth pointing out that our
study was conducted using retroviruses, which may cause genome
aberrations within the proximity of viral integrations [43]. Thus, it
will be important to investigate whether non-viral based
reprogramming (in vitro mRNA, episomal plasmids or miRNA),
direct conversion of fibroblasts [44], or drug-based protective
measures, such as modulation of ROS homeostasis, could preserve
aged somatic cells from acquiring chromosomal aberrations [45].
Finally, it is now an auspicious time for undertaking a systematic
analysis to study in detail various nuclear and mitochondrial
alterations, their functional effects and their specific risk for
oncogenic transformation.
Induced pluripotent stem cells offer a unique system to study the
cellular and molecular mechanisms underlying physiological and
pathological aging. Two prominent theories regarding cellular
aging involve the progressive loss of telomere function [46] and the
oxidative-stress mediated mitochondrial damage [11,47]. A link
between these two mechanisms has been recently suggested, as on
one hand, mitochondrial ROS could give rise to genotoxic
damage and erosion of telomeres [48], and on the other, telomere
damage could trigger a p53-mediated mitochondrial dysfunction
[49]. Moreover, advanced telomere shortening has been detected
in patients with respiratory chain dysfunction [50]. Our data
support this connection and further demonstrate that both
telomerase and mitochondrial activity are extensively modulated
upon cellular reprogramming of aged somatic cells. Additional
studies are warranted to dissect the chain of events underlying this
reprogramming-induced reversal of cellular aging. This might
eventually increase our meagre understanding of the aging process
and possibly aid in the development of therapeutic approaches
aimed to ameliorate or reverse aging-associated phenotypes.
Although our study was mainly limited to a single 84-year-old
donor, the findings were comparable in four distinct iPSC lines
derived from this individual. As an extension and further
validation of these findings, the reconfiguration of mitochondrial
functionality was confirmed in two additional iPSC lines generated
from an unrelated 82-year-old subject. At present, we cannot
exclude that the extent of the reprogramming-induced re-
establishment of hESC-like rejuvenated features may exhibit
inter-variability between individuals. Nonetheless, our data are in
agreement with recent studies conducted on somatic fibroblasts
obtained from a 70-year-old individual [25,51], from old donor
mice [35], and from young patients affected by premature aging
disorders, such as dyskeratosis congenita [36] and Hutchinson-
Gilford progeria [52,53], consensually implying that cellular
reprogramming may be capable of reversing aging-associated
phenotypes.
Overall, we have shown that fibroblasts from a very old human
donor can be coaxed into acquiring pluripotency and re-
establishing rejuvenated properties related to telomerase activity,
mitochondrial morphology and functionality, and mitochondria-
related regulation of apoptosis and ROS generation, despite the
presence of genomic alterations. Nevertheless, safeguarding the
integrity of the genome of aged somatic cells, which may exhibit
elevated susceptibility to genomic instability, will be essential
before employing iPSC-based cellular therapies for age-associated
disorders.
Materials and Methods
Ethics Statement
Adult dermal fibroblasts were obtained from full-thickness skin
biopsies originating from the sun-protected inner side of the upper
arm of patients undergoing surgery, after the approval of the study
protocol by the Ethics committee of the Charite´ Universitaetsme-
dizin Berlin (Germany) and written informed consent.
Cell culture conditions
Neonatal foreskin fibroblasts HFF1 and BJ were purchased from
ATCC (HFF1 # SCRC-1041 and BJ # SCRC -2522). Adult
dermal fibroblasts included a 56-year-old male (NFH13), an 84-
year old female (NFH2), an 80-year-old male (NFH17), and an 80-
year-old female (NFH18). Medical conditions of these subjects are
reported in Table S1. NF46 fibroblasts were obtained from an 82-
year-old woman (Hossini et al, unpublished). All fibroblast cells
were cultured in DMEM supplemented with 10% fetal calf serum,
nonessential amino acids, L-glutamine, penicillin/streptomycin
and sodium pyruvate (all from Invitrogen, CA, USA). hESCs lines
H1 and H9 were purchased from (WiCell #WA01 and #WA09,
respectively). hESCs and iPSCs were cultured in hESCs media
containing KO-DMEM supplemented with 20% knockout serum
replacement, nonessential amino acids, L-glutamine, penicillin/
streptomycin, sodium pyruvate, 0.1 mM b-mercaptoethanol (all
from Invitrogen, Carlsbad, CA) and 8 ng/ml basic fibroblast
growth factor (bFGF) (Prepotech, Rocky Hill, NJ). Cultures were
maintained on mitomycin C-inactivated mouse embryonic
fibroblast (MEFs) and passaged using the cut-and-paste technique.
Before performing experiments, feeder-free conditions were
applied and iPSCs and hESCs were grown on dishes coated with
Matrigel (BD Bioscience, San Diego) in MEF-conditioned media
(CM). All cultures were kept in a humidified atmosphere of 5%
CO2 at 37uC under atmospheric oxygen conditions. Experiments
were carried out with primary fibroblasts between passage 2 and
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passage 6 and iPSCs between passage 14 and passage 28. A
summary of all cell types used in this study is reported in Table S1.
Generation of iPS cells
HFF1-derived iPSCs (iPS2 and iPS4) and BJ-derived iPSCs (iB4
and iB5) were previously obtained using the Yamanaka retroviral
cocktail [1,10,26]. NFH2-iPSCs were derived in a similar fashion.
Briefly, pMX vector-based OCT4, KLF4, SOX2 and c-MYC
retroviruses were generated using 293T cells, according to the
conventional CaCl2 transfection protocol. 200,000 fibroblasts were
used as input for reprogramming experiments. Four weeks after
transduction, hESC-like colonies were manually picked and
expanded for characterization.
In vitro and in vivo differentiation
For in vitro differentiation, embryoid bodies (EBs) were
generated from iPSCs by harvesting the cells and seeding them
onto low-attachment dishes in differentiating medium without
bFGF supplementation. One week later, EBs were plated onto
gelatin-coated tissue culture dishes and grown for an additional ten
day period. In vivo teratoma assays were performed by EPO-Berlin
Gmbh. iPSCs were collected by trypsinization, washed and
injected s.c. into NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice,
commonly known as NOD scid gamma (NSG). Histological
analysis was performed by a certified pathologist at the Institut fu¨r
Tierpathologie in Berlin, Germany.
Neuronal differentiation
Neuronal cells were generated following a recently published
adherent protocol [32]. Briefly, pluripotent stem cells were
mechanically dissociated and grown in CM on matrigel-coated
dishes for 72 h. Differentiation was initiated by removing bFGF
and adding 10 mM SB431542 (SB) plus 1 mM PD0325901 (PD)
(both from Sigma-Aldrich, Deisenhofen, Germany). Medium was
changed daily and the cells were grown for additional 5 days and
finally fixed for immunostaining with specific antibodies.
Global gene expression analysis
Total RNA was quality-checked by Nanodrop analysis
(Nanodrop Technologies; Wilmington, DE, USA) and a quantity
of 400 ng was used as input. Biotin-labeled cRNA was produced
using a linear amplification kit (Ambion; Austin, TX, USA).
Hybridizations, washing, Cy3-streptavidin staining and scanning
were performed on the Illumina BeadStation 500 platform
(Illumina; San Diego, CA, USA), according to the manufacturer’s
instruction. cRNA samples were hybridized onto Illumina
human-8 BeadChips version 3. The following samples were
hybridized in duplicate: H1, H9, HFF1, BJ, NFH13, NFH2,
NFH17, NFH18, iPS2, iPS4, iB4, iB5, OiPS3, OiPS6, OiPS8,
and OiPS16. All basic expression data analysis was carried out
using the BeadStudio software 3.0. Raw data were background-
subtracted and normalized using the ‘‘rank invariant’’ algorithm
and then filtered for significant expression on the basis of negative
control beads. Genes were considered significantly expressed with
detection p values #0.01. Differential expression analysis was
performed using the illumina custom method; the following
parameters were set to identify statistical significance: differential
p values #0.01, fold change ratio .1.5. Heatmaps were
generated with Microarray Software Suite TM4 (TMEV.bat)
using the SA Biosciences Apoptosis PCR Array and Oxidative
Stress and Antioxidant Defense PCR Array as input gene list
(www.sabiosciences.com).
DNA fingerprinting
Fingerprinting analysis was assayed to confirm the somatic
origin of iPSCs, as previously described [26]. Briefly, genomic
DNA was isolated with the FlexiGene DNA kit (Qiagen) and PCR
amplified to detect genomic intervals containing variable numbers
of tandem repeats (VNTR). A total of 50 ng of DNA was amplified
at 94uC for 1 min, 55uC for 1 min, 72uC for 1 min for a total of 40
cycles using Dyad thermal cycler (BioRad) and then resolved on a
2.5% agarose gel.
Transmission Electron Microscopy (TEM)
Fibroblasts and pluripotent stem cells were grown on matrigel-
coated Thermanox plastic coverslips (Nalge Nunc International,
Rochester, NY, USA) until 70% confluent. Cells were then fixed
on coverslips with 2.5% glutaraldehyde in buffer A (50 mM
sodium cacodylate, pH 7.4, 50 mM sodium chloride) for 30 min
at RT. Specimens were washed 3x in the buffer A and post-fixed
for 1.5 h in 0.5% osmium tetroxide in H2O at RT, followed by
0.1% tannic acid in 100 mM HEPES, pH 7.5 for 30 min and 2%
aqueous uranyl acetate for 1.5 h. Samples were dehydrated in a
graded series of ethanol, embedded in Spurr’s resin (Low Viscosity
Spurr Kit, Ted Pella, CA, USA) and polymerised at 60uC.
Coverslips were finally removed by immersing into liquid nitrogen.
Ultra-thin sections (70 nm) were counter stained with uranyl
acetate and lead citrate for 20 sec. Micrographs were made with a
Philips CM100 using a 1 K CCD camera. Measurement of
mitochondrial diameters was performed using the EMMENU4
software (Fastscan, TVIPS).
Immunofluorescence and alkaline phosphatase staining
For immunocytochemistry, cells were fixed with 4% paraformal-
dehyde (Science Services, Munich, Germany) for 20 min at RT,
washed twice with phosphate-buffered saline without Ca2+ and
Mg2+ (PBS) and blocked with 10% chicken serum (Vector
Laboratories, Loerrach, Germany) and 0.1% Triton X-100
(Sigma-Aldrich). Nuclei were counter-stained with DAPI (200 ng/
ml, Invitrogen # H357, Karsruhe, Germany). Primary antibodies
included SSEA1, SSEA4, TRA-1-60 and TRA-1-81 from the ES
cell characterization tool (all 1:100, Millipore #SCR004, Schwal-
bach, Germany), NANOG (1:100, Abcam #ab62734, Cambridge,
UK), SMOOTH MUSCLE ACTIN (SMA) (1:100, Dako
#M0851, Hamburg, Germany), ALPHA FETO PROTEIN
(AFP) (1:100, Sigma-Aldrich #WH0000174M1), SOX17 (1:50,
R&D #AF1924, Minneapolis, MN, USA), PAX6 (1:300, Covance
#PRB-278P, Muenster, Germany), NESTIN (1:200, Chemicon
#MAB5326, Neuernberg, Germany), TUJ-1 (1:1000, Sigma-
Aldrich #T8660), BRACHYURY (T) (1:50, R&D #AF2085),
PAX6 (1:300, Covance #PRB-278P), H3K27me3 (1:100, Abcam
#ab6002). Secondary antibodies used were conjugated with either
Alexa 488 or Alexa 594 (Invitrogen #A11001, A11055, A21201,
A21468, A11005, A21442). Coverslips were mounted using Dako
fluorescent mounting medium (Dako #S3023) and visualized using
a confocal microscope LSM 510 (Carl Zeiss, Jena, Germany).
Alkaline phosphatase (AP) staining was performed following the
manufacturer’s instructions (Millipore #SCR004).
Analysis of telomerase activity
Telomerase activity was determined employing the TraPEZE
RT Telomerase Detection Kit (Millipore, #S7710, Temecula,
CA, USA), according to the recommendations of the manufac-
turer. Briefly, cell pellets of the samples were resuspended in
CHAPS Lysis Buffer and aliquots stored at 280uC. The protein
concentrations were measured by the Bradford Assay (Bio-Rad,
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#500-0205, Hercules, CA, USA). Of each sample, 100 ng of total
proteins were adjusted to a volume of 2 ml by CHAPS Lysis Buffer
and used for the Telomerase activity assay. The quantitative Real-
Time polymerase chain reactions were performed in 96-well
optical reaction plates (Applied BioSystems, Foster City, CA, USA)
using the ABI PRISM 7000 Sequence Detection System.
Reactions were carried out in triplicates using the recommended
Titanium Taq Polymerase (BD Clontech). The recommended
PCR parameters were optimized by extending the last 45uC step
from 10 sec to 30 sec. The following control reactions were
performed: telomerase positive extract control (TPC), 100 ng of
positive control cell protein extract provided by the kit adjusted to
2 ml by CHAPS Lysis Buffer, Minus telomerase Control (MTC),
cell sample substituted by 2 ml CHAPS Lysis Buffer, No template
Control (NTC), cell sample substituted by 2 ml water. For heat
inactivation controls, protein lysates were heated at 85uC for
10 min to destroy activity of telomerase. The copy number values
were calculated by converting the Ct values according to the
standard curve obtained by the TSR8 Control template reactions
(dilution series).
Detection of apoptosis
After a 24 h and 48 treatment with actinomycin D (AM)
(1029 M and 1027 M, respectively), cell apoptosis was quantified
by a cell death detection enzyme-linked immunosorbent assay
(ELISA) (Roche Diagnostics, Mannheim, Germany). The test
detects mono- and oligonucleosomes formed in apoptotic cells
according to a protocol described previously [54]. The relative
apoptosis values were normalized according to cell numbers as
measured by lactate dehydrogenase (LDH) (Roche Diagnostics)
content in the extract buffer.
Measurement of cellular production of reactive oxygen
species (ROS)
In order to determine intracellular ROS levels, the fluorescent
dye 29,79-dichloro-dihydro-fluorescein diacetate (DCF-DA) was
used. Cells were treated with 1026 M actinomycin D over 24 h
and subsequently stained with 15 mM DCF-DA (Molecular
Probes, Eugene, OR, USA) over 30 min, harvested by trypsiniza-
tion and analyzed in PBS buffer (Biochrom, Berlin, Germany) by a
FACS Canto (BD Biosciences, Heidelberg, Germany).
Karyotyping and gene expression-based analysis of
chromosomal integrity
For detection of possible karyotype abnormalities in iPSCs,
chromosomal analysis after GTG-banding was performed at the
Human Genetic Center of Berlin, Germany. For each line, 20
metaphases were counted and 12 karyograms were analyzed, as
reported earlier [26]. Enrichment or loss of whole chromosomes or
chromosomal arms was determined using the software Expander
(http://acgt.cs.tau.ac.il/expander) and EASE (http://david.abcc.
ncifcrf.gov/ease/ease1.htm), following a previously established
approach [6]. For iPSCs, the lists of up- or down-regulated genes
were obtained by comparing each iPSC line to the specific
parental fibroblast cells (.2 fold change). For hESCs, their
expression values were related to the average expression values of
all the pluripotent stem cells included in the dataset (.2 fold
change relative to grand population media). The lists of up- or
down-regulated genes were then used for location enrichment
analysis, Enrichment or loss of whole chromosomes or chromo-
somal arms was determined using the software Expander (http://
acgt.cs.tau.ac.il/expander) as previously described [6]. Chromo-
somal enrichment/loss was considered significant when Bonfer-
roni corrected p-values ,1024. Moving average plots were
produced using R/Bioconductor package GenomeGraphs.
Determination of Mitochondrial Membrane Potential
(MMP)
Relative MMP was assessed in live cells by using the fluorescent
dye tetratmethylrhodamine ethyl ester (TMRE, #T-669, Invitro-
gen, CA, USA). Human fibroblasts and undifferentiated hESCs
and iPSCs were incubated with 25 nM TMRE for 30 min at
37uC, washed twice with PBS, equilibrated with pre-warmed
culture media, and finally imaged using a Zeiss inverted
fluorescence microscope (Zeiss Axiovert 200, Carl Zeiss, Jena,
Germany) equipped with a cooled digital camera (Zeiss Axiocam,
Carl Zeiss).
Statistical analysis
Data are expressed as mean and standard deviation. Compar-
isons between two groups were performed by two-tailed unpaired
Student’s t test and P values of #0.05 were considered statistically
significant. Data were analyzed using GraphPad-Prism software
(Prism 4.0, GraphPad Software, Inc.) and Windows XP Excel
(Microsoft).
Supporting Information
Figure S1 Characterization of aged donor-derived iPSC
lines. (A) Four iPSC lines were generated from NFH2 fibroblasts
from an 84-year-old woman. All lines exhibited pluripotency-
associated alkaline phosphatase activity (AP) and NANOG protein
expression. (B) All lines were negative for SSEA1, a surface
marker of differentiated cells, and positive for the pluripotency-
associated surface markers SSEA4, TRA1-60, and TRA1-81.
Representative pictures were taken from the OiPS3 line. (C) DNA
fingerprinting analysis confirmed the somatic origin of both young
donor and aged donor-derived iPSCs.
(TIF)
Figure S2 Transcriptional profiling of NFH2-iPSCs. (A)
Table showing all the Pearson correlation values r2 between all the
single samples analyzed. For color coding, five distinct degrees of
correlation are represented: red for r2 = 1, orange for 1,r2,0.9,
yellow for 0.9,r2,0.8, light yellow for 0.8,r2,0.75, and grey for
r2,0.75. (B) Scatter plot graphs showing the between the hESCs
and NFH2-iPSCs (r2 = 0.8877), HFF1-iPSCs (r2 = 0.8190) and
NFH2-iPSCs, and NFH2 fibroblasts and NFH2-iPSCs
(r2 = 0.6682).
(TIF)
Figure S3 Teratoma formation of aged-iPSCs. In vivo
differentiation of NFH2-iPSCs. Teratoma containing structures
derivatives of the three germ layers were obtained for two lines,
OiPS6 and OiPS16. The remaining two lines, OiPS3 and OiPS8,
generated teratomas in which we could not identify structures
characteristics of the endoderm lineage (N.D. = not detected).
(TIF)
Figure S4 Gene expression-based chromosomal analy-
sis in hESCs and young donor-derived iPSCs. Significant
(Bonferroni corrected p-values ,1024) chromosomal enrichments
and chromosomal losses are indicated in red. (A) For hESCs, the
expression values were reported to the median of all the
pluripotent stem cells included in the dataset. Significantly
enrichment was detected for chromosome 12 in H1, while
significant loss was found for chromosomes 16, 19, and 20 in
both H1 and H9. (B) For iPSC lines, the expression values were
compared to the individual parental fibroblasts (iPS2 and iPS4 to
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HFF1 and iB4 and iB5 to BJ). Significantly enriched chromosomes
included chromosome 16 in iPS4, chromosome 19 in iB4, and
chromosomes 16 and 19 in iB5. Both iB4 and iB5 exhibited a
significant chromosome 3 loss.
(TIF)
Figure S5 Modulation of mitochondrial functionality in
iPSC lines derived from an additional elderly subject.
Dermal fibroblasts from an 82-year-old woman (NFH46) were
reprogrammed to pluripotency using the same viral-based protocol
(Hossini et al, unpublished). Two of the generated iPSC lines (iPS5
and iPS26B) were employed for the determination of the relative
membrane potential (MMP) using TMRE fluorescence. Both lines
exhibited higher MMP compared to the parental fibroblasts,
confirming the data obtained in the four iPSC lines derived from
NFH2 fibroblasts. Scale bars, 100 mm.
(TIF)
Figure S6 Expression of apoptosis-related genes in
fibroblasts and pluripotent stem cells. Heatmap figure
depicting the status of the apoptotic pathway. Values represent the
log2 ratio of the array average signal of the given gene divided by
the average signal of HFF1 fibroblasts (fold change 1.5, detection p
value #0.01, and differential p value #0.01). Up and down-
regulated transcripts are depicted in red and green respectively.
(TIF)
Figure S7 Expression of pluripotency-associated genes
and genes involved in the response to oxidative stress.
Heatmap figures showing representative pluripotency-associated
genes and genes related to antioxidant response. Values represent
the log2 ratio of the array average signal of the given gene divided
by the average signal of HFF1 fibroblasts (fold change 1.5,
detection p value #0.01, and differential p value #0.01). Up and
down-regulated transcripts are depicted in red and green
respectively.
(TIF)
Table S1 Summary of the cell types used in this study.
(DOC)
Table S2 Complete gene list of chromosomal enrich-
ments and chromosomal losses in all pluripotent stem
cells.
(XLS)
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